How to Start Testosterone Replacement Therapy: Best Practices

Starting testosterone replacement therapy (TRT) should begin with a diagnosis, not an advertisement promising energy or youth. The FDA says testosterone products are approved for men with low testosterone linked to an associated medical condition. Symptoms such as low libido, fewer morning erections, fatigue, depressed mood, reduced muscle, infertility, or anemia can have several causes. A clinician should confirm the pattern and obtain appropriately timed laboratory testing before discussing treatment.

The FDA’s current testosterone information describes requested June 2026 updates to age-related hypogonadism language and prostate information. Earlier actions addressed blood-pressure warnings, which remain important to review. The exact product label still controls its indication, contraindications, route, and monitoring.

Confirm the diagnosis

One low testosterone result is not enough for every patient. Levels vary with time of day, illness, sleep, medications, and laboratory method. The AUA guideline recommends morning total testosterone testing and uses symptoms plus consistently low results in its diagnostic framework. A clinician may repeat testing and investigate obesity, sleep apnea, thyroid disease, pituitary problems, diabetes, chronic illness, opioid use, or other reversible contributors.

Do not use an online questionnaire as a substitute for examination and testing. Bring outside results, a complete medication and supplement list, and a timeline of symptoms. Ask whether fertility, mood, urinary symptoms, headaches, vision changes, or breast symptoms affect the assessment.

Discuss fertility before treatment

Exogenous testosterone can suppress the signals that stimulate sperm production. A man who hopes to father a child now or later should say so before starting. A fertility-focused clinician may discuss alternatives or referral. “Feeling better” does not mean fertility is preserved. This conversation is especially important when treatment is being considered for a young man, unexplained infertility, or a couple planning pregnancy.

Choose the formulation with safety in mind

Gels, patches, short-acting injections, long-acting injections, pellets, and other formulations have different absorption, convenience, transfer, peak-and-trough, and monitoring considerations. The product’s FDA-approved labeling should be read with the prescriber. Compounded testosterone is not automatically equivalent to an FDA-approved product. Do not compare a friend’s schedule with your own or alter an amount because symptoms fluctuate.

A formulation-specific warning matters. FDA-approved Aveed (testosterone undecanoate) carries a boxed warning for serious pulmonary oil microembolism and anaphylaxis; the Aveed prescribing information requires administration through a restricted program with observation after injection. Aveed labeling also warns that testosterone can increase blood pressure and is not recommended for men with uncontrolled hypertension. These risks do not apply identically to every formulation, so the product name matters.

Set a monitoring plan

Monitoring can include symptoms, testosterone levels, hematocrit, blood pressure, fertility goals, prostate-related symptoms, sleep apnea, and adverse effects. The AUA guideline recommends an initial follow-up level after an interval appropriate to the formulation and ongoing testing every six to twelve months once stable. A clinician may monitor more closely when a risk or medication change warrants it.

Testosterone can raise hematocrit in some patients. It may worsen acne, breast tenderness, urinary symptoms, edema, or sleep-disordered breathing. Seek urgent care for chest pain, severe shortness of breath, one-sided weakness, fainting, or symptoms of a serious allergic reaction. Tell the clinician about leg swelling, severe headache, mood changes, or an erection lasting four hours or longer.

Know what improvement should look like

Libido and some sexual-function symptoms may improve over roughly three months in men who truly have testosterone deficiency, although responses vary. Body-composition changes usually take several months and depend on nutrition, resistance exercise, sleep, age, and baseline health. Bone-density changes take longer. These are ranges, not promises. If levels normalize but symptoms do not improve after an adequate three-to-six-month trial, the AUA recommends discussing whether to stop and investigate another cause.

TRT should not be used as a universal treatment for aging, athletic performance, or unexplained fatigue. A good plan includes a stopping rule, follow-up access, and a discussion of alternatives. It also respects a patient’s preference to wait while sleep, medication effects, depression, or metabolic disease are addressed.

Questions to bring to the visit

• What findings confirm testosterone deficiency?
• What reversible causes have been evaluated?
• How could treatment affect fertility, blood pressure, hematocrit, prostate symptoms, and sleep apnea?
• Which FDA-approved product is being considered, and what formulation-specific warnings apply?
• When will symptoms, levels, and safety measures be reviewed?

Atlanta Medical Institute’s low-testosterone service and hormone-care service can be discussed at the Roswell Road Atlanta office. This article is educational and does not provide a dose or injection instruction.

Decide how success will be judged

Before treatment, name the symptom that is expected to improve and how it will be tracked. Morning erections, desire, energy, anemia, and body composition are different outcomes. A normal testosterone level without symptom improvement should prompt reconsideration rather than automatic escalation. The AUA advises discussing cessation after three to six months when levels normalize but symptoms do not improve. That stopping rule protects patients from continuing a treatment that is not helping.

Ask about injection-site care, transfer risk with topical products, storage, travel, and missed appointments. Keep follow-up with the prescribing clinician and tell other healthcare professionals that you use testosterone. Coordinated records reduce duplicate prescribing and help interpret blood pressure, hematocrit, and prostate-related findings.

Discuss cost, access, and what happens if the product is unavailable. A safe plan is one you can monitor consistently.

Make the diagnosis portable

If different clinicians manage fertility, sleep apnea, primary care, and hormones, ask who coordinates results and prescription changes. Bring the original laboratory dates and collection times, rather than just saying a result was low. Confirm how urgent symptoms are reported and how routine refills are reviewed. Changing pharmacies or moving does not remove the need for follow-up. Keeping the exact product name and the reason it was prescribed in your medical record helps a new clinician assess treatment without guessing from a vial or an online schedule.